Ensysce Biosciences, Inc.
ENSC
$2.08
$0.020.97%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -27.55% | -12.84% | -15.69% | 298.16% | -69.36% |
Total Receivables | 5,377.27% | -82.27% | -93.04% | 695.18% | 133.06% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 66.39% | -5.42% | -25.93% | -17.90% | 45.97% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 31.76% | -27.39% | -49.06% | 342.48% | -23.86% |
Total Current Assets | 20.01% | -17.66% | -41.21% | 269.58% | -47.63% |
|
|||||
Total Current Assets | 20.01% | -17.66% | -41.21% | 269.58% | -47.63% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 38.88% | -16.51% | -14.14% | -12.41% | -11.04% |
Total Assets | 20.87% | -17.60% | -40.36% | 235.70% | -44.91% |
|
|||||
Total Accounts Payable | 69.48% | -54.66% | -31.03% | 308.22% | -50.90% |
Total Accrued Expenses | 17.69% | 61.99% | 22.71% | 20.75% | -9.35% |
Short-term Debt | 64.92% | -14.68% | -22.08% | -14.81% | 84.76% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 42.69% | -20.21% | -21.22% | 114.43% | -20.14% |
|
|||||
Total Current Liabilities | 42.69% | -20.21% | -21.22% | 114.43% | -20.14% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 64.92% | -14.68% | -22.08% | -14.81% | 84.76% |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -99.23% | 1,189.11% | 215.63% | -66.67% | -44.83% |
Total Liabilities | 32.92% | -14.70% | -20.95% | 113.11% | -20.40% |
|
|||||
Common Stock & APIC | 1.54% | 0.97% | 0.27% | 3.46% | 0.02% |
Retained Earnings | -1.32% | -1.50% | -2.83% | 0.52% | -1.58% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 11.15% | -17.78% | -46.32% | 282.11% | -51.78% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 11.15% | -17.78% | -46.32% | 282.11% | -51.78% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -0.03% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Equity | 12.49% | -19.51% | -48.63% | 344.75% | -56.75% |
|